Ask the expert: Is Parkinson’s disease hereditary?
Author: Johanna Stiefler JohnsonPublished: 6 May 2021
Prep: Cook: Serves:
In the latest in our ‘Ask the expert’ series, UK academic Dr Patrick Lewis discusses the “huge challenge” in trying to understand the role of genetics in Parkinson’s disease
Can genetic factors play a role in Parkinson’s disease?
Yes, they can. But the role that genetic background plays in Parkinson’s varies a huge amount between individuals. For a relatively small number of people with Parkinson’s, genetics can play a defining role in their risk of developing Parkinson’s – for others, essentially no role at all.
Estimates vary, but somewhere between 5 and 10% of people with Parkinson’s have a genetic change that either caused their Parkinson’s, or had a strong influence on their risk of developing the condition.
What do scientists know about the link between genetic factors and Parkinson’s?
Up until recently, most of the information that we had on genetics and Parkinson’s came from studying rare families where Parkinson’s was found in generation after generation, with sometimes half of a family developing symptoms.
Working with these families, geneticists and neurologists have been able to study their DNA – the complex molecule that provides the building blocks for our genes – and identify specific mutations that are found in certain genes only in members of the families that develop Parkinson’s. These mutations, which can be thought of as spelling mistakes in the genetic code, either cause someone to develop Parkinson’s or greatly increase their risk.
Over the past 10 years – and building on the huge increase in genetic research that came out of the sequencing of the human genome in 2000 – geneticists have moved beyond rare inherited forms of Parkinson’s to look at how more common genetic variants can influence how likely you are to develop Parkinson’s. These are much more difficult to identify but have greater, or more direct, relevance to most people who develop Parkinson’s.
What are scientists trying to find out?
One of the biggest challenges in understanding the link between genetic factors and Parkinson’s is figuring out precisely what a particular DNA change in a particular gene does to the function of that gene.
We’ve made huge advances in picking out these DNA changes in the last 20 years, but we are not quite so good at understanding what these DNA changes actually do to make brain cells more likely to die. So this is where a lot of research is now focused – moving from identifying genetic changes to really understanding the function of those changes.
There is also a shift to try to figure out how our genes and our environment interact to make it more or less likely that someone will develop Parkinson’s.
Dr Patrick Lewis
Do genetic factors and environmental factors have a combined effect, in terms of the risk of developing Parkinson’s?
Yes. But there is a huge difference between knowing that genetics and the environment combine to impact the risk of Parkinson’s, and really understanding how this happens.
In a way, the genetics bit is relatively straightforward. For the most part your genome stays the same from the day you are born to the day you die, although you can develop mutations through your life of course.
But the environment you live in is much more dynamic, changing and fluctuating from day to day and through the years. In some cases – for example, when considering the link between smoking and cancer – the impact of environmental factors is so strong that it becomes clear quite quickly. This has been the case in Parkinson’s for some toxins, such as the synthetic drug MPTP, which causes very specific and catastrophic damage to the bit of the brain that initiates and helps control movement.
The bulk of environmental factors are more subtle in their impact and much more difficult to identify and understand. This, in turn, makes it difficult to untangle how that might interact with an individual’s genetic background to increase or decrease the risk of developing Parkinson’s.
Take, for example, the observation that people who drink quite a lot of coffee have a slightly lower risk of developing Parkinson’s. This might be due to a chemical in coffee directly protecting your brain cells. But it might also be due to a wiring of your brain, which is partly genetically determined, that makes you more likely to drink coffee and simultaneously gives your brain more capacity to resist brain cells dying. Or it could be that there is something protective in coffee – but that there is a genetic contribution, in that some people’s genetic background makes them more likely to drink coffee. Clearly, this becomes complicated quite quickly.
Why do we need to better understand the link between genetics and Parkinson’s?
A better understanding of the genetics of Parkinson’s could help in developing new approaches to slow down or even stop the progression of the condition. The concept is pretty simple: if there is a change in a gene that causes someone to develop Parkinson’s, then reversing that change – either using a form of gene therapy or a small molecule to modify the function of the gene – can prevent the change that leads to the death of brain cells.
Actually achieving this, however, is a huge challenge – and it is an even greater challenge to move from potentially doing this for those rare mutations that cause Parkinson’s, to developing treatments that benefit the majority of people who have Parkinson’s but don’t have a strong genetic risk factor in their DNA.
There has been some progress with the former in other neurodegenerative conditions, but translating these advances to Parkinson’s will take time – and may not even be possible. The honest truth is that no one knows until it is tried.
Need to know
Dr Patrick Lewis is an academic based at the Royal Veterinary College in Camden, UK – a constituent college of the University of London. A biochemist by training, his research of the last 15 years has focused on a gene linked to Parkinson’s disease called LRRK2 (pronounced “Lurk two”). He divides his time between lecturing and conducting research, as well as writing academic research papers, grants or books, and reviewing the work of other scientists. While factors like Covid-19 have limited his time in the laboratory, he enjoys discussing and planning experiments with his students, fellow researchers and worldwide collaborators.
Genetics and Parkinson’s disease
Research suggests that a combination of genetic and environmental factors may cause Parkinson’s. While the connection appears in a small minority of people with Parkinson’s disease, scientists have found that certain genetic variants may play a role in the risk of developing the condition. A better understanding of how such genes may affect the underlying risk, onset, and progression of Parkinson’s could be important for future treatments.
To find out more about the causes of Parkinson’s, please visit the EPDA website.
Ask the expert: How can hallucinations affect people with Parkinson’s?
Professor Per Odin shares need-to-know information on the symptom
4 days ago
Regular exercise may slow progression of early Parkinson’s disease symptoms
A research team in Japan has suggested that around four hours of weekly moderate exercise is associated with a better clinical course of early-stage Parkinson’s. Their study, published in ‘Neurology’, drew on data from 237 people with the condition, whose symptoms were monitored over a period of up to six years. The research showed that people who were regularly active for at least one to two hours, one or two days a week, were better able to maintain daily activities than those who exercised less – and even experienced a “slower deterioration of processing speed”. The researchers highlighted that these benefits stemmed from maintaining regular exercise over time, rather than levels of activity at the onset of the condition. They added that their findings “suggest it may never be too late for someone with Parkinson’s to start an exercise programme”.
Could traumatic brain injury accelerate the onset of Parkinson’s disease?
Undergoing a traumatic brain injury (TBI) – a sudden injury that damages the brain – may be linked to Parkinson’s onset at an earlier age, new research suggests. The study, led by researchers in the US, examined data from the National Alzheimer’s Coordinating Centre (NACC) database and assessed whether TBI was associated with age of disease onset, survival and the degeneration of dopamine-producing nerve cells in the brain. They found that while there was no significant association with age of death or greater impact on dopamine-producing nerve cells, results showed that TBI was linked to a 4.9-year earlier age of Parkinson’s onset. Reflecting on the results, the researchers wrote that traumatic brain injury “appears to accelerate Parkinson’s onset without altering age of death”. However, the researchers also cautioned that “the nature of this relationship remains unclear”.
NASA astronaut who lived with Parkinson’s disease has died
“When I got diagnosed with Parkinson’s I thought it was over,” US astronaut Michael “Rich” Clifford once said, in a webcast conversation with Parkinson’s expert Dr Ray Dorsey. But when US space agency NASA offered him another opportunity to board a space shuttle, despite the onset of Parkinson’s symptoms, he didn’t hesitate. “And it was as easy as that.” Now, nearly 30 years since his final venture into space, Clifford has died due to complications from Parkinson’s disease. He leaves a legacy of three journeys into space, several awards for his services to the space programme – including the NASA Space Flight Medal – and a history of advocacy for people with Parkinson’s. In a 2013 conversation with the Michael J Fox Foundation, Clifford said: “Everyone with Parkinson’s handles it differently. Don’t let it get in the way of living. “Life is too good. Keep going. The sky’s the limit.” Image credit:…